Clotting Factor VII activity emerges as a highly significant predictive factor for development of cardiovascular disease (CVD) In prospective trials. We have previously shown that In hypertriglyceridemlc Individuals a fraction of their clotting Factor VII molecules is present in an activated state In phosphollpase C-sensitive complexes in plasma. These complexes may explain the increased Factor...

Clotting Factor VII activity emerges as a highly significant predictive factor for development of cardiovascular disease (CVD) in prospective trials. We have previously shown that in hypertriglyceridemic individuals a fraction of their clotting Factor VII molecules is present in an activated state in phospholipase C-sensitive complexes in plasma. These complexes may explain the increased Factor...

conclusions our study demonstrated the efficacy of rfviia in controlling postoperative bleeding in redo cardiac valve surgeries regarding subsequent blood loss and transfusion requirement; however, outcome results remains to be defined. results study groups showed no difference regarding baseline variables. three patients in rfviia group (16.67%) and 13 in placebo group (72.23%) received blood ...

The properties of mouse macrophage procoagulant induced by endotoxin in vitro were studied by the acceleration of clotting and by chromogenic assays using as substrates human plasma and bovine components, which are not activated by mouse tissue factor. Maximal macrophage procoagulant activity occurred when activated cells were lysed in culture supernatant fluids, suggesting the interaction of c...

BACKGROUND High blood levels of coagulation factor VII are associated with a risk of ischemic vascular disease. Although factor VII levels may be genetically determined, the relation between genetic polymorphisms of factor VII, factor VII blood levels, and the risk of myocardial infarction has not been established. METHODS We performed a case-control study of 165 patients with familial myocar...

Factor VII has been purified up to 330,000-fold from bovine plasma by adsorption on, and elution from, barium sulfate, anion exchange chromatography, gel filtration, and affinity chromatography on benzamidine coupled to Sepharose. The purified material is inhibited by diisopropylphosphorofluoridate both in its native state and after the formation of a complex with tissue factor in the presence ...

Factor VII has been purified up to 330,000-fold from bovine plasma by adsorption on, and elution from, barium sulfate, anion exchange chromatography, gel filtration, and affinity chromatography on benzamidine coupled to Sepharose. The purified material is inhibited by diisopropylphosphorofluoridate both in its native state and after the formation of a complex with tissue factor in the presence ...

Factor VII levels have been studied in hemophilia A and B plasmas and normal controls in a controlled, prospective study. Three assay methods were used: a standard clotting assay (FVIIc-A); a modified clotting assay (FVIIc-B) (Seligsohn et al, Blood 52:978-988, 1978); and a coupled amidolytic assay. By the FVIIc-B assay, the hemophilic plasmas were significantly lower than in the normal group (...